Early insulin therapy and the risk of cardiovascular disease in Type 2 diabetes

ISSN： 1475-0708

Source： Therapy, Vol.2, Iss.5, 2005-09, pp. : 685-688

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of pramlintide as an adjunct to basal insulin on markers of cardiovascular risk in patients with type 2 diabetes

By Wysham Carol Lush Cameron Zhang Bei Maier Holly Wilhelm Ken

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 79-85

Informa Healthcare

Access to resources Recommend Favorite

Type 2 diabetes, thiazolidinediones, and cardiovascular risk

By Taylor Clare Hobbs FD Richard

British Journal of General Practice, Vol. 59, Iss. 564, 2009-07 ,pp. : 520-524

Royal College of General Practitioners

Access to resources Recommend Favorite

Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non‐alcoholic fatty liver disease

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E42-E51

John Wiley & Sons Inc

Access to resources Recommend Favorite

Target intervention against multiple‐risk markers to reduce cardiovascular disease in patients with type 2 diabetes

By Gæde Peter Pedersen Oluf

Annals of Medicine, Vol. 36, Iss. 5, 2004-09 ,pp. : 355-366

Informa Healthcare

Access to resources Recommend Favorite

Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: Data from the Adult Diabetes Control and Management

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 14, Iss. 1, 2014-01 ,pp. : 130-137

John Wiley & Sons Inc

Access to resources Recommend Favorite